You are here: Industry Insights > Convalescent Plasma

News List

Convalescent Plasma Not Recommended in COVID-19 Drugs
December 08, 2021
Convalescent plasma is not recommended for patients with nonsevere, severe, or critical COVID-19, according to a living World Health Organization guideline published online Dec. 7 in The BMJ.
COVID-19 convalescent plasma with greater antibody levels is safe and shows promise worldpharmanews
April 07, 2021
Convalescent plasma, the use of survivors' antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists at ...
NIH pauses Covid-19 convalescent plasma trial pharmaceutical-technology
March 04, 2021
The US National Institutes of Health (NIH) has put on hold a trial of convalescent blood plasma in treating patients with mild-to-moderate Covid-19 symptoms as the study provided no significant benefit in this group.
Hackensack Meridian Health Awarded $5.5 Million by DOD to Continue COVID-19 Plasma Work americanpharmaceuticalreview
February 10, 2021
Researchers at Hackensack Meridian Health have been awarded Department of Defense funds to continue their work into convalescent plasma for treatment of COVID-19 patients.
hIVIG is good COVID-19 treatment option but faces competition from convalescent plasma expresspharma
November 02, 2020
Unlike convalescent plasma, hIVIG is a plasma product that is a standardised and concentrated mixture of polyclonal antibodies against the SARS-CoV-2.
US expands COVID-19 convalescent plasma treatment trials europeanpharmaceuticalreview
September 27, 2020
Operation Warp Speed and the NIH are funding the expansion of two trials evaluating the efficacy of convalescent plasma therapy in hospitalised COVID-19 patients.
Small Study Shows Convalescent Plasma Safe in COVID-19 Pediatric Patients americanpharmaceuticalreview
September 24, 2020
Early findings from researchers at Children's Hospital of Philadelphia (CHOP) show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19 prnewswire
September 18, 2020
Early findings from researchers at Children's Hospital of Philadelphia (CHOP) show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
Acellular-Convalescent Plasma (A-CP) and New Technologies Introduced by Regen Lab® prnasia
September 17, 2020
Convalescent Plasma (CP), also called Passive Antibody Therapy, for the treatment of COVID-19 infected patients was approved by the US-FDA two weeks ago.
FDA issues emergency use authorisation for COVID-19 convalescent plasma europeanpharmaceuticalreview
August 26, 2020
The emergency use authorisation (EUA) allows the distribution and administration of COVID-19 convalescent plasma to hospitalised patients in the US.

Previous page 1 2 Next page